Genome Editing: Technologies and Global Markets

  • ID: 3647021
  • Report
  • Region: Global
  • 129 Pages
  • BCC Research
20 % OFF
until Jun 30th 2018
1 of 5
The Global Market for Genome Editing is Forecast to Reach Over $2.0 billion by 2020

FEATURED COMPANIES

  • Addgene
  • Caribou Biosciences
  • CRISPR Therapeutics
  • Genecopoeia
  • Lonza
  • Sangamo Biosciences
  • MORE
This report provides detailed market and industry analyses of the rapidly growing global market for genome editing. Important trends of the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided through 2020.

The global market for genome editing totaled $206.0 million in 2014 and $395.0 million in 2015. The market should total over $2.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 38.9% from 2015 to 2020.

This report provides:

- An overview of the global markets and technologies for genome editing, a promising new approach that can overcome the shortcomings from site-directed mutagenesis and recombination based methods using relatively simple concepts.
- Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- A focus on the market size and segmentation of gene editing products, including gene editing tools, cell lines, animal models and potential clinical products.
- Breakdowns of the market by region, industry, application, product and type, technology, and end-user.
- A look at the recent technical breakthrough on the use of CRISPR/Cas9 and how it has fueled the rapid growth of the genome editing industry.
- A look at other growth driving factors including: the need of precision medicine for accurate genome editing technology; the increased R&D expenditure in related industrial sectors (e.g. biopharma, agriculture, and energy); increased funding for genomics research and its technological advancements; increasing demand for synthetic genes in synthetic biology; Concerns that genetically modified crops can be reduced by applying gene editing technologies to non-trangenic plant breeding.
- Exploration of emerging ethical issues.
- A relevant patent analysis.
- Profiles of key players in the industry.

Scope of the report:

This study is focused on the market side of genome editing, along with a comprehensive review of genome editing technologies with related latest progresses in the field. Different market segments for this specific market are covered. For example, application-based market segments include academic research, drug development, clinical therapy, non-transgenic breeding and other applications; and regional market segments include the U.S., Europe, Asia-Pacific and Rest of World.

Specifically, centered on the market itself and its environment, this report covers almost all aspects of the global genome editing industry, including its technologies, applications and markets, which are further segmented and analyzed by region, product type, application and technology. The report forecasts the sizes and trends of the global market as well as its each segment. It details recent technical breakthroughs as well as major technical issues to overcome before the genome editing is applied to clinic applications. The growth driving factors and the factors that may limit the market’s growth are identified. The ethical issues, regulatory issues and intellectual property right issues are discussed. The trends of patent publications, research publications and research funding in the genome editing area are analyzed. A competitive landscape, including various growth strategies and opportunities, are discussed. Comprehensive company profiles of the major players in the current genome editing field are also included in this report. In addition, the contract services market and clinical applications market are also discussed.

Highlights:

- The global market for genome editing totaled $206.0 million in 2014 and $395.0 million in 2015. The market should total over $2.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 38.9% from 2015 to 2020.
- The U.S. market for genome editing totaled $151.0 million in 2015, and should total $806.0 million by 2020, growing at a CAGR of 39.8% from 2015 to 2020.
- The genome editing market in European totaled $116.0 million in 2015 and should total $568.0 million by 2020 at a CAGR of 37.4% from 2015 to 2020

Use this report to:

- Gain insight into the genome editing market, along with a comprehensive review of genome editing technologies with related latest progresses in the field.
- Gain a clear understanding about the global market for genome editing by region, industry, application, product and type, technology, and end-user.
- Assess information about companies and their corporate profiles, and the most relevant patents.

Intended Audience:

This report is designed to satisfy the information needs of various organizations and individuals involved in the biological research, agricultural, pharmaceutical and medical research marketplaces, including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends. It is also aimed at managers and executives in marketing, research, planning and sales departments who need readable, comprehensive and up-to-date background on the marketplaces associated with the genome editing with which they are operating.

This study of the global market for genome editing has a specific focus on the various market segments, including geography-based, application-based, technological method-based and product type-based. The detailed segmentation provides a deep profiling of the global genome editing market, which is the basis of the market forecasts.

This study will be of significant interest to academic institutions, hospitals, agribio, biotech and pharmaceutical companies, biopharmaceutical researchers, marketing executives from pharmaceutical, agribio and biotech companies, contract research organizations, biologists, chemists, physicians, pharmaceutical directors, product managers and representatives, and all types of institutional directors from either public or private entities. It will also be of interest to investment bankers in the biotechnology and pharmaceutical sectors, insurance executives and life sciences product marketing managers.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Addgene
  • Caribou Biosciences
  • CRISPR Therapeutics
  • Genecopoeia
  • Lonza
  • Sangamo Biosciences
  • MORE
Chapter 1: Introduction
- Study Goals and Objectives
- Reasons for Doing this Study
- Intended Audience
- Scope of the Report
- Methodology
- Information Sources

Chapter 2: Market Summary
- Key Drivers for Market Growth

Chapter 3: Current Genome Editing Technologies
- Overview
- History of Genome Editing
- Comparison of Genome Editors
- Discovery of CRISPR/CAS9
- Components of CRISPR/CAS Systems
- How CRISPR/CAS Works
- Advantages of the CRISPR/CAS9 System
- Popularity of CRISPR Genome Editing
- Major Technological Issues
- A New Genome Editing System: CRISPR/CPF1
- Studies on Treating Diseases Using Genome Editing
- Impacts of Genome Editing
- Future of CRISPR

Chapter 4: Applications of Genome Editing
- Introduction
- Academic Research
- Drug Discovery and Development
- Clinical Therapy
- Non-Transgenic Breeding
- Other Applications

Chapter 5: Market Segmentation and Forecast
- Market Overview
- Major Players
- Market Segments by Region
- Market Segmets by Application
- Market Segments by Technology
- Market Segments by Product Type

Chapter 6: Contract Services Market Analysis
- Market Overview
- Major Players
- Market Share and Projection
- Comparison with Product Segment
- Market Overview
- Major Players
- Market Share and Projection
- Comparison with Product Segment

Chapter 7: Research Market Analysis
- Market Overview
- Marker Share and Projections
- Patent Analysis
- Publication Analysis
- Research Funding Analysis

Chapter 8: Drug Development Market Analysis
- Market Overview
- Market Share and Forecast

Chapter 9: Agricultural Biotechnology Market Analysis
- Market Overview
- Market Share and Forecast

Chapter 10: Clinical Market Analysis
- Market Overview
- Market Share and Forecast
- Comparison with Non-Clinical Market

Chapter 11: Competition Landscape and Opportunities

- Overview
- Growth Strategies
- Opportunities

Chapter 12: Factors Influencing the Genome Editing Market
- Introduction
- Driving Forces
- Factors Limiting the Market's Growth

Chapter 13: Company Profiles
- Addgene
- Agilent Technologies Inc.
- Applied StemCell Inc.
- AstraZeneca
- Calyxt
- Caribou Biosciences
- Cellecta Inc.
- Cellectis SA
- CIBUS
- Clontech Laboratories
- CRISPR Therapeutics
- Desktop Genetics
- DNA2.0
- Editas Medicine
- GE Healthcare Dharmacon
- Genecopoeia
- Genscript
- Horizon Discovery
- Innovative Genomics Initiative
- Intellia Therapeutics Inc.
- Integrated DNA Technologies
- Ixcells Biotechnologies
- Juno Therapeutics
- Lonza
- New England Biolabs
- Nova Synthetix
- Origene Technologies
- Precision Biosciences Inc.
- Recombinetics
- Regeneron Pharmaceuticals Inc.
- Sangamo Biosciences
- SIGMA-Aldrich Corp.
- Thermo Fisher Scientific
- Toolgen Inc.
- Trans Genic Inc.
- Transomic Technologies Inc.
- Transposagen Biopharmaceuticals Inc.

List of Tables

Summary Table : Global Genome Editing Market by Region Through 2020
Table 1 : Major Companies that have Business Related to Genome Editing
Table 2 : Distribution of Companies that have Genome Editing Related Businesses by Region, as of January 2016
Table 3 : Distribution of Companies that have Genome Editing Related Businesses by State in the US as of January 2016
Table 4 : Global Market for Genome Editing by Region, through 2020
Table 5 : Global Markets for Genome Editing by Application, through 2020
Table 6 : U.S. Market for Genome Editing by Application, through 2020
Table 7 :European Market For Genome Editing By Application, Through 2020
Table 8 : Asia-Pacific Market For Genome Editing By Application, Through 2020
Table 9 : Rest Of World Market For Genome Editing By Application, Through 2020
Table 10 : Global Market For Genome Editing By Technology, Through 2020
Table 11 : U.S. Market For Genome Editing By Technology, Through 2020
Table 12 : European Market For Genome Editing By Technology, Through 2020
Table 13 : Asia-Pacific Market For Genome Editing By Technology, Through 2020
Table 14 : Rest Of World Market For Genome Editing By Technology, Through 2020
Table 15 : Global Market For Genome Editing By Product Type, Through 2020
Table 16 : U.S. Market For Genome Editing By Product Type, Through 2020
Table 17 : European Market For Genome Editing By Product Type, Through 2020
Table 18 : Asia-Pacific Market For Genome Editing By Product Type, Through 2020
Table 19 : Rest Of World Market For Genome Editing By Product Type, Through 2020
Table 20 : Major Companies That Provide Genome Editing Related Services, As Of January 31, 2016
Table 21 : Global Market For Genome Editing Services By Region, Through 2020
Table 22 : Global Market For Genome Editing By Product And Service, Through 2020
Table 23 : U.S. Market For Genome Editing By Product And Service, Through 2020
Table 24 : European Market For Genome Editing By Product And Service, Through 2020
Table 25 : Asia-Pacific Market For Genome Editing By Product And Service, Through 2020
Table 26 : Rest Of World Market For Genome Editing By Product And Service, Through 2020
Table 27 : Global Academic Research Market For Genome Editing By Region, Through 2020
Table 28 : Distribution Of Genome Editing Patents And Patent Applications At Uspto By Country
Table 29 : Distribution Of U.S. Genome Editing Patents And Patent Applications At Wipo By State
Table 30 : Distribution Of Genome Editing Patents And Patent Applications At Wipo By Patent Office
Table 31 : Genome Editing Patents And Patent Applications At Uspto By Year, 2007-2015
Table 32 : Genome Editing Patents And Patent Applications At Wipo By Year, 2007-2015
Table 33 : Genome Editing Patents And Patent Applications At Uspto By Technology, 2007-2015
Table 34 : Nih Funding For Gene/Genome Editing By Year, 2007-2015
Table 35 : Nih-Funded Research Grants By Year, 2007-2015
Table 36 : Global Drug Development Market For Genome Editing By Region, Through 2020
Table 37 : Global Plant Breeding Market For Genome Editing By Region, Through 2020
Table 38 : Global Market For Genome Editing By Clinical Product And Non-Clinical Product, Through 2020
Table 39 : U.S. Market For Genome Editing By Clinical Product And Non-Clinical Product, Through 2020
Table 40 : European Market For Genome Editing By Clinical Product And Non-Clinical Product, Through 2020
Table 41 : Asia-Pacific Market For Genome Editing By Clinical Product And Non-Clinical Product, Through 2020
Table 42 : Rest Of World Market For Genome Editing By Clinical Product And Non-Clinical Product, Through 2020

List of Figures

Summary Figure : Global Genome Editing Market By Region, 2014-2020
Figure 1 : Distribution Of Companies That Have Genome Editing Related Businesses By Region, As Of January 2016
Figure 2 : Global Market For Genome Editing By Region, 2014-2020
Figure 3 : Global Genome Editing Market Share By Region, 2014
Figure 4 : Global Genome Editing Market Share By Region, 2020
Figure 5 : Global Market Shares For Genome Editing By Application, 2014
Figure 6 : Global Market Shares For Genome Editing By Application, 2020
Figure 7 : U.S. Market Shares For Genome Editing By Application, 2014
Figure 8 : U.S. Market Shares For Genome Editing By Application, 2020
Figure 9 : European Market Shares For Genome Editing By Application, 2014
Figure 10 : European Market Shares For Genome Editing By Application, 2020
Figure 11 : Asia-Pacific Market Shares For Genome Editing By Application, 2014
Figure 12 : Asia-Pacific Market Shares For Genome Editing By Application, 2020
Figure 13 : Global Market Shares For Genome Editing By Technology, 2014
Figure 14 : Global Market Shares For Genome Editing By Technology, 2020
Figure 15 : U.S. Market Shares For Genome Editing By Technology, 2014
Figure 16 : U.S. Market Shares For Genome Editing By Technology, 2020
Figure 17 : European Market Shares For Genome Editing By Technology, 2014
Figure 18 : European Market Shares For Genome Editing By Technology, 2020
Figure 19 : Asia-Pacific Market Shares For Genome Editing By Technology, 2014
Figure 20 : Asia-Pacific Market Shares For Genome Editing By Technology, 2020
Figure 21 : Global Market Shares For Genome Editing By Product Type, 2014
Figure 22 : Global Market Shares For Genome Editing By Product Type, 2020
Figure 23 : Global Market Shares For Genome Editing Services By Region, 2014
Figure 24 : Global Market Shares For Genome Editing Services By Region, 2020
Figure 25 : Global Market Shares For Genome Editing By Product And Service, 2014
Figure 26 : Global Market Shares For Genome Editing By Product And Service, 2020
Figure 27 : Global Academic Research Market Shares For Genome Editing By Region, 2014
Figure 28 : Global Academic Research Market Shares For Genome Editing By Region, 2020
Figure 29 : Genome Editing Patents And Patent Applications By Technology, 2007-2015
Figure 30 : Number Of Crispr Publications By Year, 2005-2015
Figure 31 : Number Of Zfns Publications By Year, 2005-2015
Figure 32 : Number Of Talens Publications By Year, 2011-2015
Figure 33 : Nih Funding For Gene/Genome Editing By Year, 2007-2015
Figure 34 : Nih-Funded Research Grants By Year, 2007-2015
Figure 35 : Global Drug Development Market For Genome Editing By Region, 2014
Figure 36 : Global Drug Development Market For Genome Editing By Region, 2020
Figure 37 : Global Plant Breeding Market For Genome Editing By Region, 2014
Figure 38 : Global Plant Breeding Market For Genome Editing By Region, 2020
Figure 39 : Global Clinic Genome Editing Market By Region, 2020
Figure 40 : Global Market For Genome Editing By Clinical Product And Non-Clinical Product, 2020

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Addgene
- Agilent Technologies Inc.
- Applied StemCell Inc.
- AstraZeneca
- Calyxt
- Caribou Biosciences
- Cellecta Inc.
- Cellectis SA
- CIBUS
- Clontech Laboratories
- CRISPR Therapeutics
- Desktop Genetics
- DNA2.0
- Editas Medicine
- GE Healthcare Dharmacon
- Genecopoeia
- Genscript
- Horizon Discovery
- Innovative Genomics Initiative
- Intellia Therapeutics Inc.
- Integrated DNA Technologies
- Ixcells Biotechnologies
- Juno Therapeutics
- Lonza
- New England Biolabs
- Nova Synthetix
- Origene Technologies
- Precision Biosciences Inc.
- Recombinetics
- Regeneron Pharmaceuticals Inc.
- Sangamo Biosciences
- SIGMA-Aldrich Corp.
- Thermo Fisher Scientific
- Toolgen Inc.
- Trans Genic Inc.
- Transomic Technologies Inc.
- Transposagen Biopharmaceuticals Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll